What is the maximum 24‑hour dose of metoprolol for an adult with anxiety‑related tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum 24-Hour Dose of Metoprolol for Anxiety-Related Tachycardia

For anxiety-related tachycardia, the maximum 24-hour dose of metoprolol tartrate is 400 mg daily (200 mg twice daily) and for metoprolol succinate extended-release is 400 mg once daily. 1

Formulation-Specific Maximum Dosing

Metoprolol Tartrate (Immediate-Release)

  • Maximum dose: 200 mg twice daily (400 mg total per day) 1
  • Initial dosing: 25 mg twice daily 1
  • Maintenance range: 100-200 mg twice daily 1
  • Titration interval: Every 1-2 weeks based on heart rate and blood pressure response 2

Metoprolol Succinate (Extended-Release)

  • Maximum dose: 400 mg once daily 1
  • Initial dosing: 50 mg once daily 1
  • Maintenance range: 50-400 mg once daily 1
  • Titration interval: Every 1-2 weeks as tolerated 2

Clinical Context for Anxiety-Related Tachycardia

While the guidelines primarily address supraventricular tachycardia and atrial fibrillation, the dosing parameters apply to anxiety-related tachycardia as beta-blockers reduce sympathetic drive regardless of etiology. 1

Target heart rate: Aim for resting heart rate of 50-60 beats per minute unless limiting side effects occur. 2

Absolute Contraindications Before Initiating Therapy

You must exclude these conditions before starting metoprolol at any dose:

  • AV block greater than first degree or SA node dysfunction (without pacemaker) 1
  • Decompensated systolic heart failure 1
  • Hypotension (systolic BP <100 mmHg with symptoms) 2
  • Reactive airway disease or severe asthma 1
  • Cardiogenic shock 1

Monitoring Parameters During Titration

  • Blood pressure and heart rate at each visit 2
  • Watch for symptomatic bradycardia (HR <60 bpm with dizziness or lightheadedness) 2
  • Assess for hypotension (systolic BP <100 mmHg with symptoms like dizziness or blurred vision) 2
  • Listen for new or worsening bronchospasm, particularly with any history of reactive airway disease 2

Common Adverse Effects

The most frequent side effects include:

  • Hypotension 1
  • Bradycardia 1
  • Bronchospasm 1
  • Fatigue (may appear within 2-3 weeks) 2

Critical Warnings About Discontinuation

Never abruptly discontinue metoprolol. Abrupt cessation can cause severe exacerbation of angina, myocardial infarction, ventricular arrhythmias, and has been associated with 50% mortality in one study. 2 If discontinuation is necessary, reduce the dose by 25-50% every 1-2 weeks. 2

Practical Dosing Algorithm

  1. Start low: Begin with metoprolol tartrate 25 mg twice daily or metoprolol succinate 50 mg once daily 1, 2
  2. Titrate gradually: Increase dose every 1-2 weeks based on heart rate response 2
  3. Monitor closely: Check BP and HR at each visit during titration 2
  4. Target dose: Titrate to symptom control, targeting resting HR 50-60 bpm 2
  5. Maximum limits: Do not exceed 200 mg twice daily (tartrate) or 400 mg once daily (succinate) 1

Special Considerations

Drug interactions: Use caution with other medications that cause bradycardia or AV nodal blockade, including digoxin, diltiazem, verapamil, or amiodarone. 1

Renal impairment: No dose adjustment required 3

Hepatic impairment: Initiate at low doses with cautious gradual titration, as metoprolol levels increase substantially with liver dysfunction 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metoprolol Treatment Protocol for Hypertension and Heart-Related Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.